Piperazine → Ethyl 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylate

HRID 544213Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 544213
[NH:1]1[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.[CH2:7]([O:9][C:10]([C:12]1[C:21](=[O:22])[C:20]2[C:15](=[N:16][C:17](Cl)=[C:18]([F:23])[CH:19]=2)[N:14]([CH2:25][CH3:26])[CH:13]=1)=[O:11])[CH3:8]>C(O)C>[CH2:7]([O:9][C:10]([C:12]1[C:21](=[O:22])[C:20]2[C:15](=[N:16][C:17]([N:1]3[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]3)=[C:18]([F:23])[CH:19]=2)[N:14]([CH2:25][CH3:26])[CH:13]=1)=[O:11])[CH3:8]

Komponenten

4

Edukt 2

HCID 4837PiperazineHCID 2781265HCID 2781265, Verbindung

Produkt 1

HCID 13076366Ethyl 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylate

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 702EthanolLösungsmittel

Versuchsvorschrift

A mixture of piperazine (0.86 g), the above ester (1.0 g) and ethanol (20 ml) was refluxed for 2.5 hrs. The solvent was evaporated, and the residue was extracted with chloroform. The chloroform layer was washed with water, dried over anhydrous sodium sulfate, and chloroform was evaporated. The residue was purified by chromatography to give 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid ethyl ester.

Aufarbeitung

  1. customThe solvent was evaporated
  2. extractionthe residue was extracted with chloroform
  3. washThe chloroform layer was washed with water
  4. dry with materialdried over anhydrous sodium sulfate, and chloroform
  5. customwas evaporated
  6. customThe residue was purified by chromatography

Quellen und Nachweise

ORD-Eintrag
ord-c407e85a6af4483583434c26ac2c07e0
Quelldatensatz
uspto-grants-1984_05
Patentnummer
US04448962

Notizen zur Reaktion

Wird geladen…